Close Menu

University of New Mexico

The firm aims to have its test on the European clinical market by early next year, followed by a launch in the US.

The firm's assay is designed to detect the relative abundance of bacteria species in a patient's sample, allowing doctors to improve long-term inpatient care decisions.